生殖系WT1变异国家队列的临床特征:包括晚发型表型
该研究纳入了荷兰所有遗传实验室的43例生殖系WT1变异患者,分析基因型-表型关联。结果显示,Wilms瘤风险与截短变异和缺失相关,而错义变异和剪接位点变异患者更易发生慢性肾脏病(CKD)。部分截短变异患者可晚发CKD并进展至肾衰竭,因此建议终身监测肾功能。
要点
- WT1错义变异和剪接位点变异患者CKD风险高,截短变异患者也可晚发CKD。
- Wilms瘤在截短变异和缺失患者中常见,错义/剪接位点变异中较少。
- 建议对WT1变异患者终身监测肾功能,尤其关注女孩Wilms瘤患者。
核心结论
- WT1变异存在基因型-表型关联:Wilms瘤风险与截短变异和缺失相关,CKD风险与错义及剪接位点变异相关。
- 截短变异患者也可晚发CKD并进展至肾衰竭,故推荐终身监测肾功能。
研究设计与样本
- 研究为全国性队列,纳入荷兰所有遗传实验室的43例生殖系WT1变异患者。
- 变异类型包括截短变异19例、错义变异13例、剪接位点变异7例和缺失4例。
主要发现
- Wilms瘤发生于18/19例截短变异患者和4/4例缺失患者,在错义或剪接位点变异患者中较少见。
- 所有错义变异患者和6/7例剪接位点变异患者发生CKD,而截短变异患者中5/19例发生CKD(其中3例成年后发生,肾衰竭年龄分别为24、26和41岁)。
- 缺失变异患者中1/4例发生CKD。
- 泌尿生殖系统畸形主要发生于46,XY个体。
- 10例患者以Wilms瘤为唯一临床表现,其中9例为女性。
临床怎么用
- 对WT1变异患者应终身监测肾功能,警惕晚发CKD和肾衰竭。
- 对女性Wilms瘤患者应警惕WT1变异,因其常遗漏其他表型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: WT1 disorder is a recently introduced term for phenotypes associated with germline Wilms Tumor 1 (WT1) variants, including glomerulopathy, urogenital anomalies, and Wilms tumor. Previous studies showed a bias toward missense variants in the DNA-binding/Zinc-finger domain of WT1 (exon 8 and 9) and patients with early-onset glomerulopathy. Thorough genotype-phenotype correlations including follow-up data on late-onset glomerulopathy risk are lacking. To characterize the genotypic and phenotypic spectrum of WT1 disorder, we describe a national cohort of individuals with WT1 variants. METHODS: We requested clinical and genetic data of all patients with germline WT1 variants at all Dutch genetic laboratories. RESULTS: We identified 43 patients with pathogenic WT1 variants (truncating, n = 19; missense, n = 13; splice-site, n = 7; and deletions, n = 4). Wilms tumor was the only clinical manifestation in 10 patients, of whom 9 were female. Wilms tumor occurred in 18 of 19 patients with truncating variants, in 4 of 4 patients with deletions, and was rarer in patients with missense or splice-site variants. All patients with missense and 6 of 7 with splice-site variants developed chronic kidney disease (CKD) versus 5 of 19 patients with truncating variants (3 in adulthood, with kidney failure at the age of 24, 26, and 41 years) and 1 of 4 with a deletion. Urogenital malformations occurred predominantly in 46,XY individuals. CONCLUSION: Among patients with WT1 variants, a genotype-phenotype correlation was observed for Wilms tumor risk and age of CKD onset. Although childhood-onset CKD was more common in patients with missense variants in the DNA-binding/Zinc-finger domain, other patients may develop CKD and kidney failure later in life. Therefore, life-long surveillance of kidney function is recommended. Being alert about WT1 variants is especially important for girls with Wilms tumor who often miss additional phenotypes.
引用
- van Peer SE, Kuiper RP, Hol JA, et al. Clinical Characterization of a National Cohort of Patients With Germline WT1 Variants Including Late-Onset Phenotypes. Kidney Int Rep. 2024. PMID: 39698353. doi:10.1016/j.ekir.2024.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。